Happy shareholder. They are making good progress in the development of the business and repeat business says they are kicking goals. I also like the variety of end users and particularly liked when they mention pharmaceutical companies first when talking about OEMs and prototypes. Fingers crossed there is interest in our over temp indicator within the vaccine space. Just the tip of the iceberg people!
BCT Price at posting:
3.0¢ Sentiment: Buy Disclosure: Held
